Jefferies downgraded IGM Biosciences (IGMS) to Hold from Buy with a price target of $2, down from $48, after the company discontinued all ...

Braman Motors' lawyers believe their client is the first ERISA plan sponsor to join a big group of plaintiffs with cases ...

Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

The rising prevalence of diabetes is anticipated to drive the expansion of the semaglutide market in the coming years.

Researchers developed AbMAP, a cutting-edge framework leveraging transfer learning to model antibody hypervariable regions, ...

When children receive their second measles-mumps-rubella vaccine, around the time they start kindergarten, they gain protection against all three viruses for all or most of their lives.

Best gaming logo Sanofi expands collaboration with US$2.3 billion to develop mRNA vaccines for infectious diseases! Zhengda Tianqing's Class 1 hepatitis B new drug approved for clinical trials ...

INR:8854. slot machine gratis tutte "Pharmaceutical Speed ​​Reading Club" Sanofi/Regeneron PD-1 Phase III lung cancer clinical trial terminated earl ...

SOUTH SAN FRANCISCO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Sanofi will acquire exclusive rights to develop and commercialize ...

HHS HIT WITH ANOTHER LAWSUIT — Sanofi is the latest drugmaker to sue HHS over its rejection of a plan to charge certain hospitals full price for drugs the company had previously sold at a ...